Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients — Stella

Recruiting

Back to Alcohol-related Liver Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Henry Ford Health, Detroit, Michigan

Key details

Sponsor

Henry Ford Health System

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~268 participants

Started

January 2026

Primary completion

August 2029

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov